SpriferminSprifermin (INN; development code AS-902330 ) is a recombinant human fibroblast growth factor 18 (rhFGF18) analog, originally developed by Merck, and now being further developed by TrialSpark’s subsidiary, High Line Bio (now Formation Bio), for the treatment of osteoarthritis. Read from the Drugbox of the Wikipedia article Sprifermin, revision 1318896301.

Property

Value

Formula

C876H1398N258O256S6, 19832.68 g/mol

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.